The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism

Psychoneuroendocrinology

Volumn 29, Issue 7, 2004, Pages 839-850

  Oertel, H ^a   Schneider, H J ^a   Stalla, G K ^a   Holsboer, F ^a   Zihl, J ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Attention; Cognition; Growth hormone; Hormone replacement; Hypopituitarism; Memory

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMOTION; ENERGY TRANSFER; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INTELLIGENCE; MALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; VERBAL MEMORY; WELLBEING;

ADULT; ATTENTION; COGNITION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR I; INTELLIGENCE; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RECOMBINANT PROTEINS; THYROXINE; TRIIODOTHYRONINE; VERBAL LEARNING;

EID: 2642511317     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00151-3     Document Type: Article

References (54)

1. Almqvist O., Thorén M., Sääf M., Eriksson O. Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology. 11:1986;347-352
2. Baum H.B., Katznelson L., Sherman J.C., Biller B.M., Hayden D.L., Schoenfeld D.A., Cannistraro K.E., Klibanski A. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J. Clin. Endocrinol. Metab. 83:1998;3184-3189
3. Bengtsson B.A., Edén S., Lönn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tolli J., Sjostrom L., Isaksson O.G. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. 76:1993;309-317
4. Binnerts A., Swart G.R., Wilson J.H.P., Hoogerbrugge N., Pols H.A., Birkenhager J.C., Lamberts S.W. The effect of growth hormone administration in growth hormone deficient adults on bone. protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin. Endocrinol. 37:1992;79-87
5. Björk S., Jönsson B., Westphal O., Levin J.E. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Pediatr. Scand. Suppl. 356:1989;55-59
6. Brickenkamp R. Test d2. Aufmerksamkeits-Belastungstest. 1978;Hogrefe, Göttingen
7. Burman P., Broman J.E., Hetta J., Wiklund I., Erfurth E.M., Hagg E., Karlsson F.A. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J. Clin. Endocrinol. Metab. 80:1995;3585-3590
8. Burman P., Hetta J., Karlsson A. Effect of growth hormone on brain neurotransmitters. Lancet. 342:1993;1492-1493
9. Burman P., Hetta J., Wide L., Mansson J.E., Ekman R., Karlsson F.A. Growth hormone treatment affects brain neurotransmitters and thyroxine. Clin. Endocrinol. 44:1996;319-324
10. Cuneo R.C., Salomon F., McGauley G.A., Sönksen P.H. The growth hormone deficiency syndrome in adults. Clin. Endocrinol. 37:1992;387-397
11. De Boer H., Blok G.J., Voerman B., de Vries P., Popp-Snijders C., van der Veen E. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. J. Clin. Endocrinol. Metab. 80:1995;2069-2076
12. Degerblad M., Almkvist O., Grundlitz R., Hall K., Kaijser L., Knutsson E., Ringertz H., Thoren M. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol. (Copenh.). 123:1990;185-193
13. Deijen J.B., de Boer H., Blok G.J., van der Veen E.A. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology. 21:1996;313-322
14. Deijen J.B., de Boer H., van der Veen E.A. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology. 23:1998;45-55
15. Engelmann M., Wotjak C.T., Neumann I., Ludwig M., Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci. Biobehav. Rev. 20:1996;341-358
16. Everitt B., Robbins T.W. Central cholinergic systems and cognition. A. Rev. Neurosci. 48:1997;649-684
17. Fehm-Wolfsdorf G., Born J. Behavioral effects of neurohypophyseal peptides in healthy volunteers: 10 years of research. Peptides. 12:1991;1399-1406
18. Gardner D. Synaptic transmission. Conn P.M. Neuroscience in Medicine. 1995;75-114 JB Lippincott, Philadelphia, PA
19. Holmes S.J., Shalet S.M. Characteristics of adults who wish to enter a trial of growth hormone replacement. Clin. Endocrinol. 42:1995;613-618
20. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocrinol. Rev. 17:1996;187-205
21. Hult C., Mendel-Hartvig I., Vangbo B., Öhlander C. A radioimmunoassay (RIA) for quantification of IGF-I in acid-ethanol extracted serum using truncated IGF-I as tracer. A validation report. Kabi Pharmacia Technical Report. 92:1992;96-572
22. Hunt S.M., McEwan J., McKenna S.P. Measuring health status. 1986;Croom Helm, London
23. Hyman S.E., Nestler E.J. Hyman S.E., Nestler E.J. The molecular foundations of psychiatry. 1993;56-135 American Psychiatric Press, Washington DC
24. Johannsson G., Bjarnason R., Bramnert M., Carlsson L.M., Degerblad M., Manhem P., Rosen T., Thoren M., Bengtsson B.A. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J. Clin. Endocrinol. Metab. 81:1996;1575-1581
25. Johansson J.O., Larson G., Andersson M., Elmgren A., Hynsjo L., Lindahl A., Lundberg P.A., Isaksson O.G., Lindstedt S., Bengtsson B.A. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology. 61:1995;57-66
26. Jorgensen J.O., Moller J., Laursen T., Orskov H., Christiansen J.S., Weeke J. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin. Endocrinol. 41:1994;609-614
27. Jorgensen J.O.L., Moller J., Lauritzen T., Christiansen J.S. Pharmacological aspects of growth hormone replacement therapy: route, frequency and timing of administration. Horm. Res. 33:(Suppl. 4):1990;77-82
28. Jorgensen J.O.L., Pedersen S.A., Laurberg P., Weeke J., Skakkebaek N.E., Christiansen J.S. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. J. Clin. Endocrinol. Metab. 69:1989;1127-1132
29. Kalk W.J., Vinik A.I., Pimstone B.L., Jackson P.U. Growth hormone response to insulin hypoglycemia in the elderly. J. Gerontol. 28:1973;431-433
30. Kovács G.L., de Wied D. Peptidergic modulation of learning and memory processes. Pharmacol. Rev. 46:1994;269-291
31. Kratzmeier H., Horne R. Standard progressive matrices. 1974;Raven-Matrizen-Test, Weinheim, Beltz
32. Lai Z., Emtner M., Roos P., Nyberg F. Characterization of putative growth hormone receptors in human choroid plexus. Brain Res. 546:1991;222-226
33. Lai Z., Roos P., Zhai Q. Age-related reduction of human growth hormone-binding sites in the human brain. Brain Res. 621:1993;260-266
34. Landgraf R. Intracerebrally released vasopressin and oxytocin: measurement, mechanisms and behavioral consequences. Neuroendocrinology. 7:1995;243-253
35. Mardh G., Ludin K., Borg G., Jonsson B., Lindeberg A. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: Combined data from 12 european placebo-controlled clinical trials. Endocrinol. Metab. 1:(Suppl. A):1994;43-49
36. McEwen J. The Nottingham Health Profile. Walker S.R., Rosser R.M. Assessment and application. 1987;95-111 MTP Press, Lancaster
37. McGauley G.A. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr. Scand. 356:(Suppl.):1989;70-72
38. McGauley G.A., Cuneo R.C., Salomon F., Sönksen P.H. Growth hormone deficiency and quality of life. Horm. Res. 45:1996;34-37
39. Mendlewicz J., Linkowski P., Kerkhofs M., Desmedt D., Golstein J., Copinschi G., Van Cauter E. Diurnal hypersecretion of growth hormone in depression. J. Clin. Endocrinol. Metab. 60:1985;505-512
40. O'Donnel B.F., Cohen R.A. The mutual constraint of memory and attention. Cogan R.A. The neuropsychology of attention. 1993;381-392 Plenum Press, New York
41. Oswald W.D., Roth E. Der Zahlenverbindungstest (ZVT). 1978;Hogrefe, Göttingen
42. Risby E.D., Hsiao J.K., Sunderland T., Agren H., Rudorfer M.V., Potter W.Z. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio. Clin. Pharmacol. Ther. 42:1987;547-554
43. Rosén T., Wirén L., Wilhelmsen L., Wiklund I., Bengtsson B.A. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin. Endocrinol. 40:1994;111-116
44. Rotnem D., Genel M., Hintz R., Cohen D.J. Personality development in children with growth hormone deficiency. J. Am. Acad. Child Psychiat. 16:1977;412-426
45. Sartorio A., Molinari E., Riva G., Conti A., Morabito F., Faglia G. Growth hormone treatment in adults with childhood onset growth hormone deficiency: effects on psychological capabilities. Horm. Res. 44:1995;6-11
46. Siever L.J., Trestman R.L., Coccaro E., Bernstein D., Gabriel S.M., Owen K., Moran M., Lawrence T., Rosenthal J., Horvath T.B. The growth hormone response to clonidine in acute and remitted depressed male patients. Neuropsychopharmacology. 6:1992;165-177
47. Soares C.N., Musolino N.R., Cunha N.M., Caires M.A., Rosenthal M.C., Camargo C.P., Bronstein M.D. Impact of recombinant human growth hormone (RH-GH) treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults. A placebo-controlled trial. Arq. Neuropsiquiatr. 57:1999;182-189
48. Stouthart P.J.H.M., Deijen J.B., Roffel M., Delemarre-van de Waal H.A. Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy. Psychoneuroendocrinology. 28:2003;612-626
49. Thakore J.H., Dinan T.G. Effect of fluoxetine on dexamethasone-induced growth hormone release in depression: a double-blind, placebo-controlled study. Am. J. Psychiat. 152:1995;616-618
50. Toogood A.A., O'Neil P.A., Shalet S.M. Beyond the somatopause: Growth hormone deficiency in adults over the age of 60 years. J. Clin. Endocrinol. Metab. 81:1996;460-465
51. Turchi J., Sarter M. Bidirectional modulation of basal forebrain N-methyl-D-aspartate receptor function differentially affects visual attention but not visual discrimination performance. Neuroscience. 104:2001;407-417
52. Vangbo B., Blomberg F. An improved radioimmunoassay for quantification of IGF-I in serum. A validation report. Kabi Vitrum Technical Report. 88:1988;96-431
53. Wechsler D. Wechsler Memory Scale - revised. 1987;Psychological Corporation, New York
54. Wirén L., Bengtsson B.A., Johannsson G. Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. Clin. Endocrinology. 48:1998;613-620